Continuous Erythropoietin Receptor Activator (C.E.R.A.): future new anemia treatment
Results of phase III clinical trial:
http://www.docguide.com/news/content...aemia&count=10
Continuous Erythropoietin Receptor Activator Anti-Anemia Drug Maintained Stable Hemoglobin Levels in Dialysis Patients With Up to Once Every Four Week Dosing in Phase 3 Clinical Studies
Last edited by heblaj01; 07-17-2006 at 09:31 AM..
Reason: Excessive boldface
|